Judith A. Goldman is Vice President of both Goldman & Co. and Asset Partners, Inc., responsible for investor relations. During her 40-year active involvement in the family businesses and investments, she has managed much of the accounting activities as well as property management oversight.

After being diagnosed with multiple myeloma in 1990, Judy participated in a two year clinical trial headed by the Mayo Clinic that involved an extensive chemotherapy regimen comprised of five different drugs administered both intravenously and in pill form. Following an exhaustive two-year treatment with many side effects, her physicians determined that her treatment was successful and that her disease was in remission.

Now, Judy has dedicated herself to reaching out to those with cancer through a number of advocacy efforts and support groups. She has been a voice for multiple myeloma patients through her testimony on Capitol Hill and through Illinois events such as Cancer Survivors Day. Judy also has been instrumental in working with the International Myeloma Foundation ("IMF") by founding the Midwest Action Committee ("MAC"), a regional representative of the IMF, committed to multiple myeloma patient education and support. MAC sponsors public education campaigns designed to describe the impact of multiple myeloma on patients, identify treatment options, and validate the important role that physicians must play in this cancer's management. She also continues to play a critical role in four patient groups and publishes a monthly newsletter distributed to over 300 myeloma patients, doctors and nurses. She personally maintains a hotline for newly diagnosed patients. She also has been active in several advocacy organizations.